scholarly journals How a Model of Communication Can Assist Nurses to Foster Hope When Communicating with Patients Living with a Terminal Prognosis

Religions ◽  
2017 ◽  
Vol 8 (10) ◽  
pp. 227 ◽  
Author(s):  
Rebecca Petley
Keyword(s):  
Terminal Prognosis

Communicating a terminal prognosis in a palliative care setting: Deficiencies in current communication training protocols

2008 ◽  
Vol 66 (11) ◽  
pp. 2356-2365 ◽  
Author(s):  
Elaine M. Wittenberg-Lyles ◽  
Joy Goldsmith ◽  
Sandra Sanchez-Reilly ◽  
Sandra L. Ragan
Keyword(s):  
Palliative Care ◽  
Care Setting ◽  
Communication Training ◽  
Palliative Care Setting ◽  
Terminal Prognosis ◽  
Training Protocols

The Eighth Domain of Palliative Care

2018 ◽  
Author(s):  
E. Alessandra Strada
Keyword(s):  
Palliative Care ◽  
Partner Violence ◽  
Care Setting ◽  
Ethical Issues ◽  
Complex Case ◽  
Advanced Illness ◽  
Family Conflicts ◽  
Palliative Care Setting ◽  
Case Vignettes ◽  
Terminal Prognosis

This chapter discusses palliative psychology competencies in the eighth domain of palliative care, which addresses the legal and ethical aspects of palliative care. Firstly, the chapter reviews psychology ethical standards and principles discussing their application and relevance to the palliative care setting. Palliative psychology competencies are presented. Additionally, principles of medical ethics related to decision making are discussed. Complex case scenarios are discussed with the aid of clinical case vignettes. In particular, the discussion focuses on the ethical issues related to disclosure of a terminal prognosis, family conflicts, and intimate partner violence of patients with advanced illness. Psychological approaches and interventions are discussed in the context of the interdisciplinary palliative care tem approach.

How Accurate is the Terminal Prognosis in the Minimum Data Set?

1998 ◽  
Vol 46 (8) ◽  
pp. 1023-1024 ◽  
Author(s):  
U. Harriet Finne-Soveri ◽  
Reijo S. Tilvis
Keyword(s):  
Minimum Data Set ◽  
Data Set ◽  
Minimum Data ◽  
Terminal Prognosis

scholarly journals Clinical Work Intensity Among Medical Oncologists Practicing in National Community Oncology Research Program Community Sites

2019 ◽  
Vol 15 (10) ◽  
pp. e870-e877
Author(s):  
Matthew F. Hudson ◽  
Mark A. O’Rourke ◽  
Dawn W. Blackhurst ◽  
Jennifer Caldwell ◽  
Ronnie D. Horner
Keyword(s):  
Nurse Practitioners ◽  
Clinical Work ◽  
Index Patient ◽  
Level Of Service ◽  
Work Intensity ◽  
Task Load ◽  
Provider Characteristics ◽  
Oncology Research ◽  
Medical Oncologists ◽  
Terminal Prognosis

PURPOSE: This study (1) assesses the level of clinical work intensity medical oncologists and oncologic nurse practitioners experience providing care and (2) identifies patient, provider, and practice factors mediating intensity. PATIENTS AND METHODS: Seventeen medical oncologists (12 physicians and five nurse practitioners) from five national sites national reported on the level of work intensity associated with 339 patient visits. Data collection at each site occurred over a 2- to 6 week period; for each provider, five visits were randomly selected from each of 4 randomly selected clinic days, yielding 20 visits per provider. Intensity was measured by the NASA–Task Load Index. Patient and visit characteristics were abstracted from the medical record; provider characteristics were self-reported by questionnaire. RESULTS: Clinical work intensity increased monotonically with level of service and was greatest when the visit involved discussion of either chemotherapy or terminal prognosis. Provider characteristics (including age, sex, and years of experience) were unrelated to intensity. Dimensions of work intensity that correlated directly with level of service included mental, physical, and temporal demand; effort; frustration; and stress. Perceptions of performance and of satisfaction with the visit were unrelated to level of service. Visits related to chemotherapy had greater mental, physical, and temporal demand, and effort, but worse perception of performance. When the visit involved a discussion of a terminal prognosis, greater intensity was reflected in all dimensions; stress was also greater, whereas visit satisfaction was significantly lower. CONCLUSION: Clinical work intensity increases with level of service provided and is greater for visits involving discussion of either terminal prognosis or chemotherapy.

Movement in the wrong direction: Inaccurate change in prognostic understanding and its predictors.

2019 ◽  
Vol 37 (31_suppl) ◽  
pp. 54-54
Author(s):  
Login George ◽  
Andrew S. Epstein ◽  
Holly Gwen Prigerson
Keyword(s):  
End Of Life ◽  
End Of Life Care ◽  
Terminal Illness ◽  
Religious Beliefs ◽  
Predictive Ability ◽  
Geographic Region ◽  
Cancer Type ◽  
Life Care ◽  
Advanced Cancer Patients ◽  
Terminal Prognosis

54 Background: Prognostic understanding research has primarily focused on improvements in the accuracy of patient understanding and factors driving such improvements. However, could patients with a terminal prognosis become more inaccurate in their understanding, and what factors predict such change? Methods: In a multi-site prospective study, 184 advanced cancer patients, whom oncologists expected to die within 6 months, were assessed twice (median time 5 weeks apart). Potential predictors were examined at the first assessment: age, gender, education, marital and insurance status, race, ethnicity, geographical region, cancer type, physical and psychological quality of life, and religious beliefs in end-of-life care. The accuracy of prognostic understanding was measured at both assessments using a 4-item index (understanding of terminal illness status, shortened life-expectancy, disease incurability, and advanced stage). Patients with lower prognostic understanding scores at the second assessment compared to the first assessment were categorized as demonstrating more inaccurate understanding. Results: 18.5% ( n = 34) of patients became more inaccurate in their prognostic understanding. Race ( p < .01), geographic region ( p = 0.03), and religious beliefs ( p < .01) emerged as significant correlates. Specifically, being non-white, being from South-Western/Western United States, and holding stronger religious beliefs were associated with higher likelihood of prognostic understanding becoming more inaccurate. Simultaneously examining these three predictors in a logistic regression model showed likely overlap in their predictive ability, with race ( p = 0.45) and geographic region ( p = .32 & .72, dummy coded) becoming non-significant, and religious beliefs retaining marginal significance ( p = .06). Conclusions: Some patients with a terminal prognosis may become more inaccurate in their prognostic understanding, and this may be more likely among those with stronger religious beliefs. The findings additionally raise the potential role of inaccurate prognostic understanding in contributing to the racial, religious, and regional disparities currently found in end-of-life care.

Bioactive Heterocyclic Compounds as Potential Therapeutics in the Treatment of Gliomas: A Review

2021 ◽  
Vol 21 ◽  
Author(s):  
Reyaz Hassan ◽  
Roohi Mohi-ud-din ◽  
Mohammad Ovais Dar ◽  
Abdul Jalil Shah ◽  
Prince Ahad Mir ◽  
...  
Keyword(s):  
Heterocyclic Compounds ◽  
Biological Activities ◽  
Anticancer Activities ◽  
Tumour Heterogeneity ◽  
Cancer Cell Death ◽  
Wide Range ◽  
Heterocyclic Derivatives ◽  
Current Therapies ◽  
Terminal Prognosis ◽  
Potential Therapeutics

: Cancer is one of the most alarming diseases, with an estimation of 9.6 million deaths in 2018. Glioma occurs in glial cells surrounding nerve cells. The majority of the patients with gliomas have a terminal prognosis, and the ailment has significant sway on patients and their families, be it physical, psychological, or economic wellbeing. As Glioma exhibits, both intra and inter tumour heterogeneity with multidrug resistance and current therapies are ineffective. So the development of safer anti gliomas agents is the need of hour. Bioactive heterocyclic compounds, eithernatural or synthetic,are of potential interest since they have been active against different targets with a wide range of biological activities, including anticancer activities. In addition, they can cross the biological barriers and thus interfere with various signalling pathways to induce cancer cell death. All these advantages make bioactive natural compounds prospective candidates in the management of glioma. In this review, we assessed various bioactive heterocyclic compounds, such as jaceosidin, hispudlin, luteolin, silibinin, cannabidiol, tetrahydrocannabinol, didemnin B, thymoquinone, paclitaxel, doxorubicin, and cucurbitacins for their potential anti-glioma activity. Also, different kinds of chemical reactions to obtain various heterocyclic derivatives, e.g. indole, indazole, benzimidazole, benzoquinone, quinoline, quinazoline, pyrimidine, and triazine, are listed.

Sign in / Sign up

Export Citation Format

Share Document